ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Reoperative Surgical Aortic Valve Replacement Versus Transcatheter Valve-in-Valve Replacement for Degenerated Bioprosthetic Aortic Valves

Monday, October 31, 2016

Submitted by

Mark Ferguson

Source

Source Name: Annals of Thoracic Surgery

Source URL: http://www.sciencedirect.com/science/article/pii/S0003497516305884

Author(s)

Julius I. Ejiofor, Maroun Yammine, Morgan T. Harloff, Siobhan McGurk, Jochen D. Muehlschlegel, Prem S. Shekar, Lawrence H. Cohn, Pinak Shah, Tsuyoshi Kaneko

This single institution retrospective study evaluated outcomes of valve replacement for degenerated bioprosthetic aortic valves comparing surgical AVR (SAVR) to transcatheter valve-in-valve procedures (TViV). Patients were matched into 2 groups of 22 according to STS risk scores. Operative mortality, stroke rate, and 3-year survival were similar between the groups.